Abstract
Introduction: Methotrexate (MTX) is the most generally administered antimetabolite in pediatric cancers. Renal excretion is the major route of elimination of MTX. However, renal toxicity and delayed MTX elimination is a particular concern and direct serum MTX concentration is a gold standard for renal toxicity monitoring. However, checking plasma MTX concentrations in most oncology institutions is not always possible especially in less developed countries. Objectives: The purpose of this study was to further assess the renal function after administration of high-dose MTX by parameters such as serum creatinine and Cr clearance rate. Patients and Methods: This is a cross-sectional descriptive analytic study. The study was conducted on children with acute lymphoblastic leukemia, non-Hodgkin lymphoma and osteosarcoma receiving high doses MTX. Patients’ age was ranged from 5 to 16 years. Serum MTX concentration and serum Cr were measured at 24, 48 and 96 hours after receiving MTX and then Cr clearance calculated based on available formulas. All the statistical analyses were done by SPSS 20.0 statistical software Results: This study was performed on 4 patients with osteosarcoma, 3 patients with leukemia and one patient with lymphoma. MTX concentration reduced significantly during 96 hours (P<0.001). A significant correlation between Cr clearance at 48 hours and the average of serum MTX concentration (P=0.001) were observed. Furthermore there were significant correlations between Cr at 24 hours (P=0.003), 48 hours (P=0.009) and 96 hours (P=0.044), with the average of serum MTX concentration. Conclusion: Our findings indicated that serum Cr and Cr clearance can be used to estimate the average of serum MTX concentrations.
Highlights
Methotrexate (MTX) is the most generally administered antimetabolite in pediatric cancers
Serum Cr concentration and Cr clearance at 24, 48 and 96 hours were higher in the normal elimination group compared with the delayed elimination group
Our findings showed that there is an inverse correlation between Cr at 24 (r = -0.57, P = 0.020), 48 (r = -0.57, P = 0.020) and 96 (r = -0.88, P < 0.001) hours with MTX concentration (Table 3)
Summary
Methotrexate (MTX) is the most generally administered antimetabolite in pediatric cancers. Objectives: The purpose of this study was to further assess the renal function after administration of high-dose MTX by parameters such as serum creatinine and Cr clearance rate. The study was conducted on children with acute lymphoblastic leukemia, non-Hodgkin lymphoma and osteosarcoma receiving high doses MTX. A significant correlation between Cr clearance at 48 hours and the average of serum MTX concentration (P = 0.001) were observed. There were significant correlations between Cr at 24 hours (P = 0.003), 48 hours (P = 0.009) and 96 hours (P = 0.044), with the average of serum MTX concentration. Methotrexate (MTX) is the most generally administered antimetabolite in pediatric cancers which can causes considerable improvements in the long-term survival of these patients [1,2].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
